Katherine Baicker's most recent trade in Lilly(Eli) & Co was a trade of 215 Common Stock done at an average price of $1023.3 . Disclosure was reported to the exchange on Nov. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 1023.26 per share. | 17 Nov 2025 | 215 | 23,502 (0%) | 0% | 1023.3 | 220,000 | Common Stock |
| Eli Lilly | Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 23,118 (0%) | 0% | 728.5 | 220,000 | Common Stock |
| Eli Lilly | Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 22,667 (0%) | 0% | 597.6 | 200,196 | Common Stock |
| Eli Lilly | Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 22,095 (0%) | 0% | 361.2 | 179,863 | Common Stock |
| Eli Lilly | Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 258.43 per share. | 15 Nov 2021 | 677 | 21,307 (0%) | 0% | 258.4 | 174,957 | Common Stock |